Urologist Prof. Dr. Burak Turna was invited as a Guest Faculty Member to the Regina Elena National Cancer Institute (IRE) in Rome, Italy, one of the most respected oncology centers in Europe, due to his international activities in the field of urological oncology and robotic surgery. Prof. Dr. Within the scope of his duty between 2026 and 2029, Turna will contribute to scientific research, take part in educational activities and support the development of international academic collaborations.
Acıbadem City Hospital Robotic Surgery Director Prof. Dr. Regina Elena National Cancer Institute, operating in Rome, the capital of Italy, where Burak Turna will work, is among Europe's leading reference centers in cancer diagnosis and treatment and oncology research. Combining clinical practices with advanced scientific research, the institute has an important position internationally with its activities in the fields of immunotherapy, targeted therapies, robotic surgery and personalized cancer treatments.
Prof. Dr. As part of his visiting professorship between 2026 and 2029, Burak Turna will provide training in the fields of urological oncology and robotic surgery, take part in research on advanced surgical technologies and develop joint projects with scientists from different countries.
"This mission is a sign of trust in Turkish Medicine"
Stating that the appointment is a great honor for him, Prof. Dr. Burak Turna said:
"It is a great honor for me to be invited to this position by one of the most respected cancer centers in Europe. I believe that this task is not only a personal academic achievement, but also an important indicator of the trust that Turkish medicine and the robotic surgery experience in our country receive in the international arena. Over the next three years, we will continue to represent our country in the best way and use the scientific knowledge and experience we will gain for the benefit of our patients in Türkiye."
Prof. Dr. It is planned that Turna will take part in international research projects, contribute to the education of young surgeons, take part in multidisciplinary cancer activities and carry out scientific activities regarding the clinical applications of new technologies developed in robotic surgery.
In addition to contributing to the strengthening of scientific collaborations between Turkey and Europe's leading cancer centers, the international assignment is expected to make a significant contribution to making the academic knowledge in the field of Turkish urology and robotic surgery more visible on international platforms. - IZMIR